# ESRP1-Associated CD44 Alternative Splicing Stratifies Epithelial–Mesenchymal Identity States in a Non-Transformed Human Cell System

**Authors:** Karolina Bajdak-Rusinek, Natalia Diak, Anna Trybus, Agnieszka Fus-Kujawa, Marcelina Salamon, Jan Olszewski, Weronika Wójtowicz, Patrycja Rozwadowska-Kunecka

PMC · DOI: 10.3390/cimb48020130 · Current Issues in Molecular Biology · 2026-01-24

## TL;DR

The study explores how CD44 splicing and ESRP1 relate to epithelial-mesenchymal identity states in non-cancer human cells.

## Contribution

It introduces a non-transformed human cell system to study epithelial–mesenchymal plasticity outside of cancer contexts.

## Key findings

- CD44 splicing patterns correlate with epithelial–mesenchymal identity states in non-transformed cells.
- ESRP1 regulates CD44 splicing, with silencing shifting splicing toward epithelial-associated forms.
- Notch-related transcription varies across identity states, showing context-dependent behavior.

## Abstract

Epithelial–mesenchymal plasticity encompasses a spectrum of epithelial and mesenchymal identity states that enable cells to adapt to changing biological contexts. While CD44 isoform usage and epithelial splicing regulators ESRP1/2 are well-characterized in cancer-associated epithelial–mesenchymal transition (EMT), their regulation across physiological, non-transformed identity states remains less well defined. Here, we employed a non-malignant human cellular system comprising primary dermal fibroblasts, induced pluripotent stem (iPS) cells, and iPS-derived mesenchymal stem cells (iPS-MSCs) to define discrete epithelial, intermediate epithelial/mesenchymal, and mesenchymal identity states positioned along an epithelial–mesenchymal identity axis. Morphological assessment, lineage marker profiling, and RT-qPCR analyses revealed reproducible population-level stratification of these states. CD44 expression and alternative splicing followed this hierarchy, with CD44s predominating in fibroblasts, broad variant exon inclusion in iPS cells, and intermediate patterns in iPS-MSCs. ESRP1 expression mirrored CD44 splicing architecture, and ESRP1 silencing in iPS cells induced a shift toward CD44s, confirming its functional contribution to epithelial-associated CD44 splicing. In contrast, Notch-related transcriptional readouts displayed distinct, context-dependent profiles across the examined identity states. Together, this study establishes a tractable non-transformed human model that captures selected molecular features associated with epithelial–mesenchymal plasticity beyond malignant contexts.

## Linked entities

- **Genes:** ESRP1 (epithelial splicing regulatory protein 1) [NCBI Gene 54845], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960]
- **Proteins:** cd44.S (CD44 molecule (IN blood group) S homeolog)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** KLF4 (KLF transcription factor 4) [NCBI Gene 9314] {aka EZF, GKLF}, VTN (vitronectin) [NCBI Gene 7448] {aka V75, VN, VNT}, HEY1 (hes related family bHLH transcription factor with YRPW motif 1) [NCBI Gene 23462] {aka BHLHb31, CHF2, HERP2, HESR1, HRT-1, NERP2}, VIM (vimentin) [NCBI Gene 7431], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, NT5E (5'-nucleotidase ecto) [NCBI Gene 4907] {aka CALJA, CD73, E5NT, NT, NT5, NTE}, ZEB1 (zinc finger E-box binding homeobox 1) [NCBI Gene 6935] {aka AREB6, BZP, DELTAEF1, FECD6, NIL2A, PPCD3}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, ESRP2 (epithelial splicing regulatory protein 2) [NCBI Gene 80004] {aka RBM35B}, ESRP1 (epithelial splicing regulatory protein 1) [NCBI Gene 54845] {aka DFNB109, RBM35A, RMB35A}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, FUT4 (fucosyltransferase 4) [NCBI Gene 2526] {aka CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX}, RBFOX2 (RNA binding fox-1 homolog 2) [NCBI Gene 23543] {aka FOX2, Fox-2, HNRBP2, HRNBP2, RBM9, RTA}, CDH1 (cadherin 1) [NCBI Gene 999] {aka Arc-1, BCDS1, CD324, CDHE, ECAD, LCAM}, SLTM (SAFB like transcription modulator) [NCBI Gene 79811] {aka Met}, HEY2 (hes related family bHLH transcription factor with YRPW motif 2) [NCBI Gene 23493] {aka CHF1, GRIDLOCK, GRL, HERP1, HESR2, HRT2}, HES1 (hes family bHLH transcription factor 1) [NCBI Gene 3280] {aka HES-1, HHL, HRY, bHLHb39}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}
- **Diseases:** cancer (MESH:D009369), injury to (MESH:D014947), hypoxia (MESH:D000860), metastasis (MESH:D009362)
- **Chemicals:** methanol (MESH:D000432), ethanol (MESH:D000431), Alexa Fluor  488 (MESH:C000711379), A1517001 (-), Oligofectamine (MESH:C484027), PBS (MESH:D007854), agarose (MESH:D012685)
- **Species:** Mycoplasma (genus) [taxon 2093], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PCS-201- — Mus musculus (Mouse), Hybridoma (CVCL_LN00), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12939047/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939047/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12939047/full.md

---
Source: https://tomesphere.com/paper/PMC12939047